Pincus T - Search Results

1

What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols?

Pincus T, Stein CM. Pincus T, et al. J Rheumatol. 1995 Sep;22(9):1611-7. J Rheumatol. 1995. PMID: 8523331 No abstract available.

2

Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.

Pincus T, Richardson B, Strand V, Bergman MJ. Pincus T, et al. Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-47-54. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365089

3

Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.

Pincus T, Braun J, Kavanaugh A, Smolen JS. Pincus T, et al. Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-1. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365080 No abstract available.

4

Assessment of quality of rheumatoid arthritis care requires joint count and/or patient questionnaire data not found in a usual medical record: examples from studies of premature mortality, changes in clinical status between 1985 and 2000, and a QUEST-RA global perspective.

Sokka T, Haugeberg G, Pincus T. Sokka T, et al. Among authors: pincus t. Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):86-97. Clin Exp Rheumatol. 2007. PMID: 18021512

5

An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.

Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R. Pincus T, et al. Rheumatology (Oxford). 2008 Mar;47(3):345-9. doi: 10.1093/rheumatology/kem364. Epub 2008 Jan 31. Rheumatology (Oxford). 2008. PMID: 18238788

6

Benefit/risk of therapies for rheumatoid arthritis: underestimation of the "side effects" or risks of RA leads to underestimation of the benefit/risk of therapies.

Pincus T, Kavanaugh A, Sokka T. Pincus T, et al. Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S2-11. Clin Exp Rheumatol. 2004. PMID: 15552508 Review.

7

Rheumatoid arthritis: a medical emergency?

Pincus T. Pincus T. Scand J Rheumatol Suppl. 1994;100:21-30. doi: 10.3109/03009749409095198. Scand J Rheumatol Suppl. 1994. PMID: 7863269 Review.

8

What is the natural history of rheumatoid arthritis?

Pincus T, Callahan LF. Pincus T, et al. Rheum Dis Clin North Am. 1993 Feb;19(1):123-51. Rheum Dis Clin North Am. 1993. PMID: 8356248 Review.

9

An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.

Sokka T, Pincus T. Sokka T, et al. Among authors: pincus t. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S178-81. Clin Exp Rheumatol. 2005. PMID: 16273804

10

Partial control of Core Data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: evidence from longitudinal observations over 5-20 years.

Pincus T, Sokka T. Pincus T, et al. Clin Exp Rheumatol. 2002 Sep-Oct;20(5 Suppl 27):S42-7. Clin Exp Rheumatol. 2002. PMID: 14989429 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results